Press Releases

Company News
View Summary Acura Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call on August 4, 2015
Jul 27, 2015
PDF 11.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Raise Approximately $7.6 Million From Institutional Healthcare Investors
Jul 1, 2015
PDF 13.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals USPTO Issues Notice of Allowance for Novel Limitx(TM) Abuse Deterrent Technology
Jun 29, 2015
PDF 14.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Partners Its Methamphetamine Resistant Impede(R) Technology
Jun 16, 2015
PDF 12.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces First Quarter 2015 Financial Results
May 4, 2015
PDF 22.4 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host First Quarter 2015 Financial Results Conference Call on May 5, 2015
Apr 21, 2015
PDF 11.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Develop Abuse Deterrent Hydrocodone With Acetaminophen Tablets With Limitx(TM) Technology
Apr 9, 2015
PDF 14.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Reports Successful Topline Results From Nexafed(R) Extended-Release Clinical Study
Mar 23, 2015
PDF 13.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2014 Financial Results
Mar 2, 2015
PDF 26.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host 2014 Financial Results Conference Call on March 3, 2015
Feb 23, 2015
PDF 11.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals Initiates Clinical Study of Meth-Resistant Nexafed(R) Extended-Release Formulations
Feb 16, 2015
PDF 16.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Expands Meth-Resistant Decongestant Line With NEXAFED(R) Sinus Pressure + Pain
Feb 5, 2015
PDF 14.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Partners With Egalet Corporation to Commercialize Immediate Release Oxycodone Product Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Jan 8, 2015
PDF 14.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Acknowledges Distribution of Nexafed(R) by Kmart Pharmacy
Dec 23, 2014
PDF 12.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Receives Additional U.S. Patent for Abuse Deterrent Drug Formulations
Dec 8, 2014
PDF 11.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Third Quarter 2014 Financial Results
Nov 3, 2014
PDF 26.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Third Quarter 2014 Financial Results Conference Call on November 4, 2014
Oct 28, 2014
PDF 11.2 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Update on Its Hydrocodone Bitartrate With Acetaminophen Tablets Development
Oct 16, 2014
PDF 15.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Hydrocodone Bitartrate With Acetaminophen Tablets Meet Clinical Endpoints
Sep 29, 2014
PDF 17.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Submits Formal Dispute Resolution Request With FDA Regarding Hydrocodone Bitartrate With Acetaminophen Tablets
Sep 15, 2014
PDF 15.9 KB Add to Briefcase
Showing 1-20 of 90 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase